• Info
  • Insider Ownership

Insider Trading & Ownership of Neil E. Stahl

Location
Tarrytown, NY
Summary
The estimated net worth of Neil E. Stahl is at least $43,324,609 dollars as of 18 Dec 2024. Neil E. Stahl is the EVP Research and Development of REGENERON PHARMACEUTICALS, INC. and owns shares of REGENERON PHARMACEUTICALS, INC. (REGN) stock worth about $43.32M.
Signature
/s/ Neil E. Stahl
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Neil E. Stahl and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to follow filing activity

Sponsored

Quick Takeaways

  • Neil E. Stahl has 1 issuer position tracked on this page.
  • Estimated disclosed ownership value: $43,324,609.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: REGENERON PHARMACEUTICALS, INC. ($43,324,609).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Neil E. Stahl

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
REGN REGENERON PHARMACEUTICALS, INC. EVP Research and Development $43,324,609 16 Dec 2024

Insider Transactions Reported by Neil E. Stahl:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored